After 14 years in academia researching dosage form design, Chris van der Walle moved to the biopharmaceutical industry, first developing formulations for monoclonal antibodies in MedImmune and then mRNA-lipid nanoparticles in AstraZeneca. He led the formulation team in GlaxoSmithKline developing […]
Dr. Maciej Drozdz, MBA has over 15 years of experience spanning biotechnology investment, company creation, and technology commercialization. Throughout his career, he has held roles as an investor, board member, and operating executive across a range of life science companies. […]
Aishu Parthasarathy is an Associate at Sofinnova Partners’ Digital Medicine fund, where she focuses on early-stage healthcare and biotech companies at the intersection of AI and life sciences. Her interest in AI was shaped by her academic work in neuroscience, […]
With over 15 years of experience in the life sciences industry, Barbara Beneduci has developed deep expertise in advancing innovative solutions and fostering strategic partnerships in the biopharma industry. After earning a master’s degree in biotechnology, she began her career […]
Sizhen Li is a Computational Scientist Lead at Sanofi, specializing in computational biology with a focus on mRNA vaccine design and RNA structure prediction. She earned her PhD in Computer Science from Oregon State University in 2020, where her research […]
Trained as an immunologist at the Pasteur Institute (Paris, France), Steve Pascolo used mouse models to test and develop mRNA-based vaccines (direct injection of mRNA) during his post-doc in Tuebingen, Germany from 1998 till 2000. In 2000, he co-founded CureVac […]
Dr. Xiaojing Gao received a B.S. in Biology from Peking University and a Ph.D. in Biology from Stanford University. He received his postdoctoral training from Biology and Biological Engineering at Caltech. His recent recognitions include BioInnovation Institute & Science Prize […]
Dr. Rein Verbeke is a senior postdoc in the Ghent Research Group on Nanomedicines (Ghent University, https://www.drugdelivery.be ). His PhD focused on the design of mRNA-LNPs and the adjuvancy of mRNA vaccines. Rein continued his research on the validation of […]
Olivia Merkel has been a Professor of Drug Delivery at LMU Munich since 2015, Chair since 2022, and Co-Director of the Department of Pharmacy since 2024. She is a Registered Pharmacist, received a MS (2006) and a PhD (2009) in […]
Dr. Jeremie Parot is a senior research scientist at SINTEF (Norway), bringing his expertise in analytical chemistry and a passion for exploring the fascinating world of nanoparticles. He is actively engaged in the design, optimization, and production of RNA-LNPs, seeking […]
14 – 15 October, 2026 | Lisbon, Portugal
© 2017 Copyright All Rights Reserved | Powered by EPM Group
